| 1 |
34064886 | A Whole-Body Physiologically Based Pharmacokinetic Model Characterizing Interplay of OCTs and MATEs in Intestine, Liver and Kidney to Predict Drug-Drug Interactions of Metformin with Perpetrators. | 2021 May 11 |
1 |
| 2 |
26702643 | The Nonmetabolized β-Blocker Nadolol Is a Substrate of OCT1, OCT2, MATE1, MATE2-K, and P-Glycoprotein, but Not of OATP1B1 and OATP1B3. | 2016 Feb 1 |
1 |
| 3 |
27019345 | Metformin and cimetidine: Physiologically based pharmacokinetic modelling to investigate transporter mediated drug-drug interactions. | 2016 Jun 10 |
2 |
| 4 |
26552145 | [Establishment of MDCK cell models expressing human MATE1 or co-expressing with human OCT1 or OCT2]. | 2015 Jul |
1 |
| 5 |
22072731 | Competitive inhibition of the luminal efflux by multidrug and toxin extrusions, but not basolateral uptake by organic cation transporter 2, is the likely mechanism underlying the pharmacokinetic drug-drug interactions caused by cimetidine in the kidney. | 2012 Feb |
2 |
| 6 |
20977453 | Modulation of drug block of the cardiac potassium channel KCNA5 by the drug transporters OCTN1 and MDR1. | 2010 Nov |
2 |
| 7 |
19357179 | Organic cation transporters OCT1, 2, and 3 mediate high-affinity transport of the mutagenic vital dye ethidium in the kidney proximal tubule. | 2009 Jun |
1 |
| 8 |
17614008 | Comparison of the kinetic characteristics of inhibitory effects exerted by biguanides and H2-blockers on human and rat organic cation transporter-mediated transport: Insight into the development of drug candidates. | 2007 Jun |
1 |